newsLaunch of generic oncology medications to improve treatment access in India2 March 2021 | By Hannah Balfour (European Pharmaceutical Review)GlobalData suggests the recent approval of new generics in oncology should enhance access and adherence to cancer treatment by reducing costs borne by patients.
newsGlenmark approved to supply favipiravir as COVID-19 treatment in India23 June 2020 | By Victoria Rees (European Pharmaceutical Review)Indian authorities have given their first approval for the oral antiviral favipiravir for treatment of COVID-19 to Glenmark Pharmaceuticals.
newsGlenmark recalls iohexol solution batches as precautionary measure10 February 2020 | By Victoria Rees (European Pharmaceutical Review)Out of specification results from stability studies have led Glenmark Pharmaceuticals to recall batches of their iohexol solution for injection in the UK.
articleThe 10 latest FDA Orphan Drug Designations for cancer treatments25 September 2019 | By Victoria Rees (European Pharmaceutical Review)The FDA grants Orphan Drug Designation to treatments for rare diseases in R&D; here are the 10 most recent for oncologic conditions.
newsMultiple myeloma treatment granted Orphan Drug Designation18 September 2019 | By Rachael Harper (European Pharmaceutical Review)Orphan Drug Designation has been given to bispecific antibody candidate, GBR 1342, for the treatment of multiple myeloma.
newsFDA clears Glenmark’s HER2+ cancer drug for Phase I trial3 January 2017 | By Niamh Louise Marriott, Digital EditorPreclinical studies suggest GBR 1302 may have activity against a range of HER2-expressing tumour types, including breast, gastric and other cancers...
newsSun shines on Indian generics manufacturers3 April 2013 | By GlobalDataIndia is becoming a key market for generic medicines...
newsSanofi and Glenmark Pharmaceuticals sign license agreement on Novel Monoclonal Antibody for Crohn’s Disease17 May 2011 | By Glenmark PharmaceuticalsSanofi to develop molecule for Crohn’s Disease & other anti-inflammatory conditions...
